ruthenium has been researched along with daunorubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kessel, D; Wilberding, C | 1 |
| Aldrich-Wright, JR; Beck, JL; Ralph, SF; Sheil, MM; Urathamakul, T | 1 |
| Guo, DD; Li, YZ; Wang, XM; Wu, CH; Wu, DH; Yan, H | 1 |
3 other study(ies) available for ruthenium and daunorubicin
| Article | Year |
|---|---|
Effects of ruthenium red on accumulation and cytotoxicity of m-AMSA, vinblastine and daunorubicin in leukemia cells.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Division; Cell Line; Daunorubicin; Leukemia P388; Leukemia, Experimental; Mice; Ruthenium; Ruthenium Red; Vinblastine | 1984 |
A mass spectrometric investigation of non-covalent interactions between ruthenium complexes and DNA.
Topics: Dactinomycin; Daunorubicin; DNA; Organometallic Compounds; Ruthenium; Spectrometry, Mass, Electrospray Ionization | 2004 |
Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2-dichalcogenolate ligand--in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Crystallography, X-Ray; Daunorubicin; Electrochemistry; Ferrous Compounds; Humans; Ligands; Microscopy, Confocal; Models, Chemical; Molecular Structure; Organometallic Compounds; Ruthenium | 2009 |